TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program October 25, 1985
TCL Archive White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis July 22, 1977
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Simone, LoBuglio Lead AACI; AMA Honors B.J. Kennedy; FDA Meet Patient Advocates July 31, 1992
